Claim.MD Achieves HITRUST Risk-Based, 2-year (r2) Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance

HITRUST Risk-based, 2-year (r2) Certification validates Claim.MD is committed to strong cybersecurity and meeting key regulations to protect sensitive data

PECOS, NM / ACCESSWIRE / July 11, 2023 / Claim.MD, a leading electronic data interchange (EDI) clearinghouse helping to streamline the billing and collection process for providers, payers and software vendors, today announced the Claim.MD Clearinghouse Service has earned certified status by HITRUST for information security.

HITRUST Risk-based, 2-year (r2) Certified status demonstrates that the organization’s Clearinghouse Service has met demanding regulatory compliance and industry-defined requirements and is appropriately managing risk. This achievement places Claim.MD in an elite group of organizations worldwide that have earned this certification. By including federal and state regulations, standards, and frameworks, and incorporating a risk-based approach, the HITRUST Assurance Program helps organizations address security and data protection challenges through a comprehensive and flexible framework of prescriptive and scalable security controls.

“Organizations like ours are continually under pressure to address current and emerging threats and meet complex compliance, information protection, and privacy requirements,” said Rob Stuart, founder and president, Claim.MD. “We are pleased to demonstrate to our customers the highest standards for data protection and information security by achieving the rigorous HITRUST Risk-based, 2-year Certification.”

Claim.MD helps healthcare providers, software vendors and insurance carriers easily manage electronic medical transactions. Designed with the provider in mind, Claim.MD’s medical providers enjoy increased cash flow by streamlining their electronic transactions. With Claim.MD, providers control their claims from filing to payment – reducing costly staff time to research and correct rejected claims. When claim follow-up with a payer is necessary, Claim.MD simplifies the process with a complete and readable claim history that can be printed for proof of timely filing.

“The HITRUST Assurance Program is rigorous and reliable because of the comprehensiveness of control requirements, depth of review, and consistency of oversight,” said Bimal Sheth, Executive Vice President, Standards Development & Assurance Operations, HITRUST. “HITRUST Risk-based, 2-year (r2) Certification demonstrates Claim.MD is taking the most proactive approach to cybersecurity, data protection, and risk management.”

About Claim.MD
Founded in the early 1980s, Claim.MD is a leading EDI Clearinghouse which processes tens of millions of transactions every month. The company’s extensive insurance network links providers to Medicare, Medicaid, Blue, and thousands of commercial insurance companies across the country. Designed with the provider in mind, Claim.MD’s cost-effective and robust product and service offerings are designed to meet provider collection goals. The company’s system of tools is designed to help providers send clean claims the first time, and offer visual tracking to easily see issues and collection trends as industry billing situations change. For more information, visit: https://www.claim.md/

Press contact information:
Tom Testa
Anderson Interactive
tom@andersoni.com

###

SOURCE: Claim.MD

View source version on accesswire.com:
https://www.accesswire.com/766482/ClaimMD-Achieves-HITRUST-Risk-Based-2-year-r2-Certification-to-Further-Mitigate-Risk-in-Third-Party-Privacy-Security-and-Compliance

Staff

Recent Posts

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

33 minutes ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

2 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

2 hours ago

Hallmark Adds Senior Executives to Enhance Customer Success and Strategic Partnerships

New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…

2 hours ago

CARESYNTAX ANNOUNCES 2024 HIGHLIGHTS

 Company Celebrates Continued Worldwide Progress Toward Data-Driven Surgery SAN FRANCISCO and BERLIN, Dec. 23, 2024…

3 hours ago

Medit Launches a Mobile App, MEDIT M, to Revolutionize Digital Dental Workflows

SEOUL, South Korea, Dec. 23, 2024 /PRNewswire/ -- Medit has launched a mobile app, MEDIT…

3 hours ago